STOCK TITAN

[Form 4] Cryo-Cell International Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4
Rhea-AI Filing Summary

Fastly, Inc. (FSLY) – Form 144 filing discloses that insider Ronald W. Kisling intends to sell additional Fastly Class A common shares under Rule 144.

  • Proposed sale: 7,294 shares, estimated proceeds ≈ $51,422, to be executed on or about 16 Jul 2025 through E*TRADE on the NYSE.
  • Historical activity: Over the last three months Kisling has already sold 35,982 shares for ≈ $267,138. Adding the new notice brings total planned/realised disposals to 43,276 shares (≈ $318,560).
  • Ownership context: The 7,294-share block equals roughly 0.005% of the 147.17 million shares outstanding, indicating de minimis dilution impact.

The filing is routine for insiders seeking to comply with Rule 144 resale requirements. While continued sales may raise sentiment questions, the volumes are immaterial relative to Fastly’s public float and are unlikely to exert observable price pressure on their own. No information regarding motives, 10b5-1 plans, or any undisclosed material developments is provided, and the signatory affirms no knowledge of non-public adverse information.

Fastly, Inc. (FSLY) – Deposito modulo 144 rivela che l'insider Ronald W. Kisling intende vendere ulteriori azioni ordinarie di Classe A di Fastly secondo la Regola 144.

  • Vendita proposta: 7.294 azioni, proventi stimati ≈ 51.422$, da eseguire intorno al 16 luglio 2025 tramite E*TRADE sulla NYSE.
  • Attività storica: Negli ultimi tre mesi Kisling ha già venduto 35.982 azioni per ≈ 267.138$. Con questa nuova comunicazione, il totale delle cessioni pianificate/realizzate sale a 43.276 azioni (≈ 318.560$).
  • Contesto di proprietà: Il blocco di 7.294 azioni rappresenta circa lo 0,005% delle 147,17 milioni di azioni in circolazione, indicando un impatto diluitivo de minimis.

Il deposito è una prassi per gli insider che devono rispettare i requisiti di rivendita della Regola 144. Sebbene vendite continue possano sollevare dubbi sul sentiment, i volumi sono irrilevanti rispetto al flottante pubblico di Fastly e difficilmente eserciteranno una pressione osservabile sul prezzo. Non sono fornite informazioni su motivazioni, piani 10b5-1 o sviluppi materiali non divulgati, e il firmatario conferma di non essere a conoscenza di informazioni negative non pubbliche.

Fastly, Inc. (FSLY) – Presentación del Formulario 144 revela que el insider Ronald W. Kisling planea vender acciones adicionales ordinarias Clase A de Fastly bajo la Regla 144.

  • Venta propuesta: 7,294 acciones, ingresos estimados ≈ 51,422$, a ejecutarse alrededor del 16 de julio de 2025 a través de E*TRADE en la NYSE.
  • Actividad histórica: En los últimos tres meses Kisling ya vendió 35,982 acciones por ≈ 267,138$. Con este nuevo aviso, el total de disposiciones planificadas/realizadas asciende a 43,276 acciones (≈ 318,560$).
  • Contexto de propiedad: El bloque de 7,294 acciones representa aproximadamente el 0.005% de las 147.17 millones de acciones en circulación, indicando un impacto dilutivo de minimis.

La presentación es rutinaria para insiders que buscan cumplir con los requisitos de reventa de la Regla 144. Aunque las ventas continuas pueden generar dudas sobre el sentimiento, los volúmenes son insignificantes en relación con el flotante público de Fastly y es poco probable que ejerzan presión observable sobre el precio por sí solos. No se proporciona información sobre motivos, planes 10b5-1 ni desarrollos materiales no divulgados, y el firmante afirma no tener conocimiento de información adversa no pública.

Fastly, Inc. (FSLY) – Form 144 제출 내부자 Ronald W. Kisling이 Rule 144에 따라 추가 Fastly Class A 보통주를 판매할 계획임을 공개했습니다.

  • 제안된 판매: 7,294주, 예상 수익 약 51,422달러, 2025년 7월 16일경 E*TRADE를 통해 NYSE에서 실행 예정.
  • 과거 활동: 최근 3개월 동안 Kisling은 이미 35,982주를 약 267,138달러에 판매했습니다. 이번 공지가 추가되면 총 계획/실현 처분 주식 수는 43,276주(약 318,560달러)가 됩니다.
  • 소유권 맥락: 7,294주 블록은 전체 1억 4,717만 주 중 약 0.005%에 해당하며, 이는 de minimis 수준의 희석 영향임을 나타냅니다.

이 제출은 Rule 144 재판매 요건을 준수하려는 내부자들에게 일반적인 절차입니다. 지속적인 매도는 투자 심리에 의문을 제기할 수 있으나, 거래량은 Fastly의 공개 주식수에 비해 미미하여 단독으로 가격에 유의미한 압력을 가할 가능성은 낮습니다. 동기, 10b5-1 계획 또는 미공개 중대한 사항에 대한 정보는 제공되지 않았으며, 서명자는 비공개 불리한 정보가 없음을 확인했습니다.

Fastly, Inc. (FSLY) – Dépôt du formulaire 144 révèle que l'initié Ronald W. Kisling prévoit de vendre des actions ordinaires de classe A supplémentaires de Fastly conformément à la règle 144.

  • Vente proposée : 7 294 actions, produit estimé ≈ 51 422 $, à exécuter aux alentours du 16 juillet 2025 via E*TRADE sur le NYSE.
  • Activité historique : Au cours des trois derniers mois, Kisling a déjà vendu 35 982 actions pour ≈ 267 138 $. Avec cette nouvelle notification, le total des cessions planifiées/réalisées s'élève à 43 276 actions (≈ 318 560 $).
  • Contexte de propriété : Le bloc de 7 294 actions représente environ 0,005 % des 147,17 millions d'actions en circulation, indiquant un impact dilutif de minimis.

Le dépôt est une procédure courante pour les initiés cherchant à se conformer aux exigences de revente de la règle 144. Bien que des ventes continues puissent susciter des interrogations sur le sentiment du marché, les volumes sont insignifiants par rapport au flottant public de Fastly et sont peu susceptibles d'exercer une pression observable sur le prix à eux seuls. Aucune information concernant les motifs, les plans 10b5-1 ou des développements matériels non divulgués n'est fournie, et le signataire affirme ne pas avoir connaissance d'informations défavorables non publiques.

Fastly, Inc. (FSLY) – Form 144 Einreichung offenbart, dass Insider Ronald W. Kisling beabsichtigt, zusätzliche Fastly Class A Stammaktien gemäß Rule 144 zu verkaufen.

  • Vorgeschlagener Verkauf: 7.294 Aktien, geschätzter Erlös ≈ 51.422 $, Ausführung etwa am 16. Juli 2025 über E*TRADE an der NYSE.
  • Historische Aktivität: In den letzten drei Monaten hat Kisling bereits 35.982 Aktien für ≈ 267.138 $ verkauft. Mit der neuen Meldung steigt die Gesamtzahl der geplanten/realisierten Veräußerungen auf 43.276 Aktien (≈ 318.560 $).
  • Eigentumskontext: Das Paket von 7.294 Aktien entspricht etwa 0,005 % der 147,17 Millionen ausstehenden Aktien und deutet auf eine de minimis Verwässerungswirkung hin.

Die Einreichung ist Routine für Insider, die die Anforderungen der Rule 144 zum Wiederverkauf erfüllen müssen. Obwohl fortgesetzte Verkäufe Fragen zum Marktgefühl aufwerfen können, sind die Volumina im Verhältnis zum öffentlichen Streubesitz von Fastly unerheblich und dürften allein keinen spürbaren Preisdruck ausüben. Es werden keine Informationen zu Motiven, 10b5-1-Plänen oder nicht veröffentlichten wesentlichen Entwicklungen bereitgestellt, und der Unterzeichner bestätigt, keine Kenntnis von nicht öffentlichen nachteiligen Informationen zu haben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Minor insider sale; negligible dilution; neutral share-price effect.

This Form 144 covers 7,294 additional shares (<0.01% of float). Aggregate insider disposals of ~43 k shares since April translate to <0.03% of outstanding stock, far below thresholds that typically move markets. The filing signals nothing about operations or guidance and simply establishes Rule 144 compliance. Overall market impact is expected to be neutral.

TL;DR: Ongoing insider selling warrants monitoring but is not materially significant.

Regular, modest sales can reflect diversification rather than negative outlook. However, cumulative disposals over three months may attract governance watchers if the trend accelerates. Investors should watch for any clustering of insider sales ahead of earnings or strategic announcements, although current volume remains too small to raise red flags.

Fastly, Inc. (FSLY) – Deposito modulo 144 rivela che l'insider Ronald W. Kisling intende vendere ulteriori azioni ordinarie di Classe A di Fastly secondo la Regola 144.

  • Vendita proposta: 7.294 azioni, proventi stimati ≈ 51.422$, da eseguire intorno al 16 luglio 2025 tramite E*TRADE sulla NYSE.
  • Attività storica: Negli ultimi tre mesi Kisling ha già venduto 35.982 azioni per ≈ 267.138$. Con questa nuova comunicazione, il totale delle cessioni pianificate/realizzate sale a 43.276 azioni (≈ 318.560$).
  • Contesto di proprietà: Il blocco di 7.294 azioni rappresenta circa lo 0,005% delle 147,17 milioni di azioni in circolazione, indicando un impatto diluitivo de minimis.

Il deposito è una prassi per gli insider che devono rispettare i requisiti di rivendita della Regola 144. Sebbene vendite continue possano sollevare dubbi sul sentiment, i volumi sono irrilevanti rispetto al flottante pubblico di Fastly e difficilmente eserciteranno una pressione osservabile sul prezzo. Non sono fornite informazioni su motivazioni, piani 10b5-1 o sviluppi materiali non divulgati, e il firmatario conferma di non essere a conoscenza di informazioni negative non pubbliche.

Fastly, Inc. (FSLY) – Presentación del Formulario 144 revela que el insider Ronald W. Kisling planea vender acciones adicionales ordinarias Clase A de Fastly bajo la Regla 144.

  • Venta propuesta: 7,294 acciones, ingresos estimados ≈ 51,422$, a ejecutarse alrededor del 16 de julio de 2025 a través de E*TRADE en la NYSE.
  • Actividad histórica: En los últimos tres meses Kisling ya vendió 35,982 acciones por ≈ 267,138$. Con este nuevo aviso, el total de disposiciones planificadas/realizadas asciende a 43,276 acciones (≈ 318,560$).
  • Contexto de propiedad: El bloque de 7,294 acciones representa aproximadamente el 0.005% de las 147.17 millones de acciones en circulación, indicando un impacto dilutivo de minimis.

La presentación es rutinaria para insiders que buscan cumplir con los requisitos de reventa de la Regla 144. Aunque las ventas continuas pueden generar dudas sobre el sentimiento, los volúmenes son insignificantes en relación con el flotante público de Fastly y es poco probable que ejerzan presión observable sobre el precio por sí solos. No se proporciona información sobre motivos, planes 10b5-1 ni desarrollos materiales no divulgados, y el firmante afirma no tener conocimiento de información adversa no pública.

Fastly, Inc. (FSLY) – Form 144 제출 내부자 Ronald W. Kisling이 Rule 144에 따라 추가 Fastly Class A 보통주를 판매할 계획임을 공개했습니다.

  • 제안된 판매: 7,294주, 예상 수익 약 51,422달러, 2025년 7월 16일경 E*TRADE를 통해 NYSE에서 실행 예정.
  • 과거 활동: 최근 3개월 동안 Kisling은 이미 35,982주를 약 267,138달러에 판매했습니다. 이번 공지가 추가되면 총 계획/실현 처분 주식 수는 43,276주(약 318,560달러)가 됩니다.
  • 소유권 맥락: 7,294주 블록은 전체 1억 4,717만 주 중 약 0.005%에 해당하며, 이는 de minimis 수준의 희석 영향임을 나타냅니다.

이 제출은 Rule 144 재판매 요건을 준수하려는 내부자들에게 일반적인 절차입니다. 지속적인 매도는 투자 심리에 의문을 제기할 수 있으나, 거래량은 Fastly의 공개 주식수에 비해 미미하여 단독으로 가격에 유의미한 압력을 가할 가능성은 낮습니다. 동기, 10b5-1 계획 또는 미공개 중대한 사항에 대한 정보는 제공되지 않았으며, 서명자는 비공개 불리한 정보가 없음을 확인했습니다.

Fastly, Inc. (FSLY) – Dépôt du formulaire 144 révèle que l'initié Ronald W. Kisling prévoit de vendre des actions ordinaires de classe A supplémentaires de Fastly conformément à la règle 144.

  • Vente proposée : 7 294 actions, produit estimé ≈ 51 422 $, à exécuter aux alentours du 16 juillet 2025 via E*TRADE sur le NYSE.
  • Activité historique : Au cours des trois derniers mois, Kisling a déjà vendu 35 982 actions pour ≈ 267 138 $. Avec cette nouvelle notification, le total des cessions planifiées/réalisées s'élève à 43 276 actions (≈ 318 560 $).
  • Contexte de propriété : Le bloc de 7 294 actions représente environ 0,005 % des 147,17 millions d'actions en circulation, indiquant un impact dilutif de minimis.

Le dépôt est une procédure courante pour les initiés cherchant à se conformer aux exigences de revente de la règle 144. Bien que des ventes continues puissent susciter des interrogations sur le sentiment du marché, les volumes sont insignifiants par rapport au flottant public de Fastly et sont peu susceptibles d'exercer une pression observable sur le prix à eux seuls. Aucune information concernant les motifs, les plans 10b5-1 ou des développements matériels non divulgués n'est fournie, et le signataire affirme ne pas avoir connaissance d'informations défavorables non publiques.

Fastly, Inc. (FSLY) – Form 144 Einreichung offenbart, dass Insider Ronald W. Kisling beabsichtigt, zusätzliche Fastly Class A Stammaktien gemäß Rule 144 zu verkaufen.

  • Vorgeschlagener Verkauf: 7.294 Aktien, geschätzter Erlös ≈ 51.422 $, Ausführung etwa am 16. Juli 2025 über E*TRADE an der NYSE.
  • Historische Aktivität: In den letzten drei Monaten hat Kisling bereits 35.982 Aktien für ≈ 267.138 $ verkauft. Mit der neuen Meldung steigt die Gesamtzahl der geplanten/realisierten Veräußerungen auf 43.276 Aktien (≈ 318.560 $).
  • Eigentumskontext: Das Paket von 7.294 Aktien entspricht etwa 0,005 % der 147,17 Millionen ausstehenden Aktien und deutet auf eine de minimis Verwässerungswirkung hin.

Die Einreichung ist Routine für Insider, die die Anforderungen der Rule 144 zum Wiederverkauf erfüllen müssen. Obwohl fortgesetzte Verkäufe Fragen zum Marktgefühl aufwerfen können, sind die Volumina im Verhältnis zum öffentlichen Streubesitz von Fastly unerheblich und dürften allein keinen spürbaren Preisdruck ausüben. Es werden keine Informationen zu Motiven, 10b5-1-Plänen oder nicht veröffentlichten wesentlichen Entwicklungen bereitgestellt, und der Unterzeichner bestätigt, keine Kenntnis von nicht öffentlichen nachteiligen Informationen zu haben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Berger Harold D.

(Last) (First) (Middle)
700 BROOKER CREEK BLVD
SUITE 1800

(Street)
OLDSMAR FL 34677

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 50,401 D
Common Stock 07/08/2025 M 7,500 A $3.08 57,901 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option $7.53 08/30/2019 08/30/2029 Common Stock 7,500 7,500 D
Stock Option $7.74 11/25/2019 11/25/2029 Common Stock 5,300 5,300 D
Stock Option $7.85 09/22/2020 09/22/2030 Common Stock 5,300 5,300 D
Stock Option $12.63 10/20/2021 10/20/2031 Common Stock 5,300 5,300 D
Stock Option $6.5 10/03/2022 10/03/2032 Common Stock 5,300 5,300 D
Stock Option $4.9 10/10/2023 10/10/2033 Common Stock 5,300 5,300 D
Stock Option $5.82 10/29/2024 10/29/2034 Common Stock 5,300 5,300 D
Stock Option $3.08 07/08/2025 M 7,500 07/09/2015 07/09/2025 Common Stock 7,500 $3.08 0 D
Explanation of Responses:
/s/ Harold Berger 07/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Fastly (FSLY) file?

Fastly submitted a Form 144 indicating an insider’s intent to sell shares under Rule 144.

How many Fastly shares are being proposed for sale?

The notice covers 7,294 Class A common shares, valued at approximately $51,423.

Who is the Fastly insider selling the shares?

The seller is Ronald W. Kisling, whose address is listed in the filing.

When is the planned sale date?

The approximate sale date disclosed is July 16, 2025.

How many shares has this insider sold recently?

Kisling sold 35,982 shares in the past three months and will reach 43,276 shares if the new sale is completed.

What percentage of Fastly’s outstanding shares does the proposed sale represent?

About 0.005% of the 147.17 million shares outstanding.
Cryo-Cell Intl Inc

NYSE:CCEL

CCEL Rankings

CCEL Latest News

CCEL Stock Data

40.81M
4.42M
47.59%
12.76%
0.18%
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
OLDSMAR